245 related articles for article (PubMed ID: 8136373)
1. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
Mayfield C; Squibb M; Miller D
Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
[TBL] [Abstract][Full Text] [Related]
2. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding.
Cogoi S; Ballico M; Bonora GM; Xodo LE
Cancer Gene Ther; 2004 Jul; 11(7):465-76. PubMed ID: 15118760
[TBL] [Abstract][Full Text] [Related]
4. Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein.
Chen S; Supakar PC; Vellanoweth RL; Song CS; Chatterjee B; Roy AK
Mol Endocrinol; 1997 Jan; 11(1):3-15. PubMed ID: 8994183
[TBL] [Abstract][Full Text] [Related]
5. G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells.
Cogoi S; Quadrifoglio F; Xodo LE
Biochemistry; 2004 Mar; 43(9):2512-23. PubMed ID: 14992588
[TBL] [Abstract][Full Text] [Related]
6. Effect of abasic linker substitution on triplex formation, Sp1 binding, and specificity in an oligonucleotide targeted to the human Ha-ras promoter.
Mayfield C; Miller D
Nucleic Acids Res; 1994 May; 22(10):1909-16. PubMed ID: 8208618
[TBL] [Abstract][Full Text] [Related]
7. Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages.
Cogoi S; Rapozzi V; Quadrifoglio F; Xodo L
Biochemistry; 2001 Feb; 40(5):1135-43. PubMed ID: 11170438
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
Kim HG; Miller DM
Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
[TBL] [Abstract][Full Text] [Related]
9. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
10. Guanine-rich oligonucleotides targeted to a critical R . Y site located in the Ki-ras promoter. The effect of competing self-structures on triplex formation.
Alunni-Fabbroni M; Manzini G; Quadrifoglio F; Xodo LE
Eur J Biochem; 1996 May; 238(1):143-51. PubMed ID: 8665931
[TBL] [Abstract][Full Text] [Related]
11. Triplex formation inhibits HER-2/neu transcription in vitro.
Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
[TBL] [Abstract][Full Text] [Related]
12. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
13. Triple helix formation by purine-rich oligonucleotides targeted to the human dihydrofolate reductase promoter.
Blume SW; Gee JE; Shrestha K; Miller DM
Nucleic Acids Res; 1992 Apr; 20(7):1777-84. PubMed ID: 1579471
[TBL] [Abstract][Full Text] [Related]
14. Triplex formation by the human Ha-ras promoter inhibits Sp1 binding and in vitro transcription.
Mayfield C; Ebbinghaus S; Gee J; Jones D; Rodu B; Squibb M; Miller D
J Biol Chem; 1994 Jul; 269(27):18232-8. PubMed ID: 8027084
[TBL] [Abstract][Full Text] [Related]
15. Interactions of cytosine derivatives with T.A interruptions in pyrimidine.purine.pyrimidine DNA triplexes.
Verma S; Miller PS
Bioconjug Chem; 1996; 7(5):600-5. PubMed ID: 8889023
[TBL] [Abstract][Full Text] [Related]
16. Effect of cations on purine.purine.pyrimidine triple helix formation in mixed-valence salt solutions.
Floris R; Scaggiante B; Manzini G; Quadrifoglio F; Xodo LE
Eur J Biochem; 1999 Mar; 260(3):801-9. PubMed ID: 10103010
[TBL] [Abstract][Full Text] [Related]
17. DNA triple helix formation at target sites containing several pyrimidine interruptions: stabilization by protonated cytosine or 5-(1-propargylamino)dU.
Gowers DM; Bijapur J; Brown T; Fox KR
Biochemistry; 1999 Oct; 38(41):13747-58. PubMed ID: 10521282
[TBL] [Abstract][Full Text] [Related]
18. Strong, specific, monodentate G-C base pair recognition by N7-inosine derivatives in the pyrimidine.purine-pyrimidine triple-helical binding motif.
Marfurt J; Parel SP; Leumann CJ
Nucleic Acids Res; 1997 May; 25(10):1875-82. PubMed ID: 9115352
[TBL] [Abstract][Full Text] [Related]
19. Targeting neighbouring poly(purine.pyrimidine) sequences located in the human bcr promoter by triplex-forming oligonucleotides.
Xodo LE; Rathinavelan T; Quadrifoglio F; Manzini G; Yathindra N
Eur J Biochem; 2001 Feb; 268(3):656-64. PubMed ID: 11168404
[TBL] [Abstract][Full Text] [Related]
20. A kinetic study of triple-helix formation at a critical R x Y sequence of the murine c-Ki-ras promoter by (A,G)- and (G,T) oligonucleotides.
Xodo LE; Pirulli D; Quadrifoglio F
Eur J Biochem; 1997 Sep; 248(2):424-32. PubMed ID: 9346298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
